JO3721B1 - Administration of Dipeptidyl Peptidase inhibitors - Google Patents

Administration of Dipeptidyl Peptidase inhibitors

Info

Publication number
JO3721B1
JO3721B1 JOP/2006/0308A JOP20060308A JO3721B1 JO 3721 B1 JO3721 B1 JO 3721B1 JO P20060308 A JOP20060308 A JO P20060308A JO 3721 B1 JO3721 B1 JO 3721B1
Authority
JO
Jordan
Prior art keywords
administration
dipeptidyl peptidase
peptidase inhibitors
pharmaceutical compositions
methyl
Prior art date
Application number
JOP/2006/0308A
Other languages
Arabic (ar)
Inventor
Ronald J Christopher
Paul Covington
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40125749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JO3721(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Application granted granted Critical
Publication of JO3721B1 publication Critical patent/JO3721B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pharmaceutical compositions comprising 2-((6-(3R)-3-Amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-Pyrimidinyl)methyl)-benzonitrile AND Pharmaceutical ACCEPTABLE SALTS THEREOF ARE PROVIDED AS WELL AS Kits and articles of manufacture comprising the Pharmaceutical compositions as well as methods of using the Pharmaceutical compositions.
JOP/2006/0308A 2005-09-14 2006-09-13 Administration of Dipeptidyl Peptidase inhibitors JO3721B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71755805P 2005-09-14 2005-09-14

Publications (1)

Publication Number Publication Date
JO3721B1 true JO3721B1 (en) 2021-01-31

Family

ID=40125749

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2006/0308A JO3721B1 (en) 2005-09-14 2006-09-13 Administration of Dipeptidyl Peptidase inhibitors

Country Status (4)

Country Link
AR (1) AR108699A2 (en)
JO (1) JO3721B1 (en)
UA (1) UA91717C2 (en)
ZA (1) ZA200802855B (en)

Also Published As

Publication number Publication date
AR108699A2 (en) 2018-09-19
UA91717C2 (en) 2010-08-25
ZA200802855B (en) 2009-11-25

Similar Documents

Publication Publication Date Title
MY159522A (en) Administration of dipeptidyl peptidase inhibitors
TW200744602A (en) Administration of dipeptidyl peptidase inhibitors
MX2009002772A (en) Administration of dipeptidyl peptidase inhibitors.
UA101313C2 (en) Normal;heading 1;heading 2;heading 3;WEEKLY ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS
ATE430747T1 (en) 2-PYRIMIDINYL-PYRAZOLOPYRIDINE ERBB KINASE INHIBITORS
SG166828A1 (en) Aminopyrimidines useful as kinase inhibitors
DE602006021776D1 (en) AMINOPYRIMIDINES SUITABLE AS KINASEINHIBITORS
MX2009006690A (en) Aminopyrimidines useful as inhibitors of protein kinases.
TW200740815A (en) P38 MAP kinase inhibitors and methods for using the same
MX2009009591A (en) Aminopyrimidines useful as inhibitors of protein kinases.
TW200607505A (en) Fused heterocyclic kinase inhibitors
WO2007067506A3 (en) 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors
MX2009006345A (en) Compounds useful as protein kinase inhibitors.
ATE542814T1 (en) PYRAZINE KINASE INHIBITORS
WO2007120333A3 (en) Tetracyclic kinase inhibitors
MX2009005231A (en) Compounds useful as protein kinase inhibitors.
JO3721B1 (en) Administration of Dipeptidyl Peptidase inhibitors
JO3254B1 (en) Dipeptidyl Peptidase inhibitors for Treating diabetes
UA95260C2 (en) 4-(3-aminopyrazole) pyrimidine derivative and use thereof in the treatment of cancer
UA99112C2 (en) Use of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydr0-2h-pyrimidin-1-ylmethyl]-4-fluorobenzonitrile